openPR Logo
Press release

Rituximab Biosimilars Market Is Booming Worldwide (2020-2023) | By Top Leading Players – Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd.

09-28-2020 07:33 AM CET | Health & Medicine

Press release from: The Business research company

The Business Research Company

The Business Research Company

The Business Research Company offers "Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

The global rituximab biosimilars market is expected to decline from $1.84 billion in 2019 to $1.78 billion in 2020 at a compound annual growth rate (CAGR) of -3.22%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The market is then expected to recover and reach $2.62 billion in 2023 at a CAGR of 13.85%.

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3430

The rituximab biosimilars market consists of sales of rituximab biosimilars. Biosimilars are pharmaceuticals that are manufactured using cell lines and are similar to biologics. Rituximab biosimilars are used as a single agent or in combination with chemotherapy for the treatment of various diseases including chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL), microscopic polyangiitis (MPA), and granulomatosis with polyangiitis (GPA).

The companies operating in the biosimilars market are continuously focusing on new product development in collaborations with other companies in the industry. Innovation through partnerships is shaping the rituximab biosimilars market.

Rituximab Biosimilars Market Segmentation:
By Application
1. Non-Hodgkin’s lymphoma,
2. Chronic Lymphocytic Leukemia,
3. Rheumatoid arthritis, Others

Hospital Pharmacy
1. Hospital Pharmacy,
2. Online Pharmacy,
3. Retail Pharmacy,
4. Other Direct Distribution Channels.

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/rituximab-biosimilars-global-market-report-2020-30-covid-19-growth-and-change

Few Points From Table Of Content
1. Executive Summary
2. Rituximab Biosimilars Market Characteristics
3. Rituximab Biosimilars Market Size And Growth
4. Rituximab Biosimilars Market Segmentation
5. Rituximab Biosimilars Market Regional And Country Analysis
……
25. Rituximab Biosimilars Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Rituximab Biosimilars Market
27. Rituximab Biosimilars Market Trends And Strategies
28. Rituximab Biosimilars Market Future Outlook and Potential Analysis
29. Appendix

The report covers the trends and market dynamics of the rituximab biosimilars market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3430&type=smp

Some of the key players involved in the rituximab biosimilars market are Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Celltrion Healthcare Co. Ltd., Sandoz International GmbH, Reliance Life Sciences, C.H. Boehringer Sohn AG & Ko. KG, BioXpress Therapeutics SA, Intas Biopharmaceuticals Ltd

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rituximab Biosimilars Market Is Booming Worldwide (2020-2023) | By Top Leading Players – Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd. here

News-ID: 2144042 • Views: 401

More Releases from The Business research company

Women's Wear Market Research Report 2020-2021: Growth Factors, Top Manufacturers …
The Business Research Company offers " Women's Wear Global Market Report 2020" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the
Site Remediation Consulting Services Market Size, Share, Growth, Opportunities A …
The Business Research Company offers " Site Remediation Consulting Services Global Market Report 2020" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also
Architectural Services Market Research Report 2020 – Segments, Competitive Ana …
The Business Research Company offers " Architectural Services Global Market Report 2020" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the
2020 Men's Wear Market size and Forecast | Industry overview, latest Trend and G …
The Business Research Company offers "Men`s Wear Market Global Report 2020" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s

All 5 Releases


More Releases for Rituximab

Pemphigus Vulgaris Market 2026 Top Key Players are Principia Biopharma, Argenx S …
Pemphigus vulgaris is an autoimmune disorder in which painful blisters are formed on the mucus membrane and skin. The disorder is rare and affects mouth, nose, throat, lungs, eyes, and sometimes genitals. The disorder is caused when the body produces antibodies against self-cells, although the exact cause and mechanism is unknown. Formation of Immunoglobulin G (IgG) antibodies against self desmosomal adhesion proteins, present on epidermal keratinocytes, results in blister formation.
Global Rituximab Biosimilar Market 2027: Top Key Players Amgen Inc., Pfizer Inc. …
Rituximab is a chimeric anti-CD20 antibody that binds to the CD20 antigen present on the normal and malignant B cells surface. It is indicated for the treatment of blood cancer (CD20-positive) such as chronic lymphocytic leukemia and non-Hodgkin’s lymphoma as well as autoimmune disorder such as Rheumatoid arthritis. Rituximab is marketed under the trade name of MabThera in Europe and rest of World, except Japan by Roche. In the United
Global Rituximab biosimilar market is expected to grow at rapid pace with strong …
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on ' Global Rituximab Biosimilar Market Assessment – Revenue Forecast, Clinical Trial/Pipeline Analysis, Brand/Originator Drug Historic Revenue and Forecast Till 2026' Request for ToC/Proposal: https://bit.ly/2SoYrjn Rituximab is a chimeric anti-CD20 antibody that binds to the CD20 antigen present on the normal and malignant B cells surface. It is indicated for the treatment of blood cancer (CD20-positive) such as chronic lymphocytic leukemia
Rituxan (rituximab) Drug Market 2018-2023: Industry Share, Size, Statistics, App …
The report on Rituxan (rituximab) Drug market evaluates the growth trends of the industry through historical study 2013-2018 and estimates future prospects 2018-2023 based on comprehensive research. Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. Over the next five years, RRI projects that Rituxan (rituximab) Drug will register a xx% CAGR in terms of revenue, reach US$ xx
CD Antigen Cancer Therapy Market Outlook and Clinical Trials Insight 2023 Report
“CD Antigen Cancer Therapy Market Outlook and Clinical Trials Insight 2023” report highlights: * Market Opportunity Assessment: More than US$ 60 Billion by 2023 * Clinical and Patent Insight on 17 Commercialize CD Antigen Drugs * Clinical and Licensing Insight on 184 CD Antigens in Clinical Pipeline * Dosage and Price Analysis on Key Drugs * Mechanism of CD Antigen Cancer Therapeutics * Cancer CD Antigens Clinical Pipeline Dominated by CD20 Antigen: 50
Feb 13, 2018: Rituximab Market In-Depth Progress Research 2018-2025
MarketsResearch.Biz Recently added detailed market study on the "Global Rituximab Market Research Report 2018-2025" which provides an outlook of current market value of Rituximab Market as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% in Rituximab Market by the end of 2025. The report on the global Rituximab market uses the top-down and bottom-up approaches to define, analyze, and describe the Rituximab market